Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methadone maintenance treatment: an update

G Bertschy1

  • 1Département Universitaire de Psychiatrie Adulte, Prilly-Lausanne, Switzerland.

European Archives of Psychiatry and Clinical Neuroscience
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and tolerance of combination of monoamine oxidase inhibitors and direct dopamine agonists in adults and older adults with highly resistant depression.

L'Encephale·2023
Same author

Impact of the first wave of the COVID-19 pandemic on French Health students.

L'Encephale·2022
Same author

Misdiagnosis in three boys with predominantly hyperactive ADHD.

L'Encephale·2020
Same author

Racing and crowded thoughts in mood disorders: A data-oriented theoretical reappraisal.

L'Encephale·2020
Same author

Incidence and risk factors of venous thromboembolism: Peculiarities in psychiatric institutions.

International journal of cardiology·2017
Same author

[IDEM-depression: Characteristics and evaluation of an open group that combines psychoeducation and cognitive-behavior therapy].

L'Encephale·2016
Same journal

Major depressive disorder-alcohol use disorder comorbidity: diagnosis, mechanisms and treatment.

European archives of psychiatry and clinical neuroscience·2026
Same journal

The interplay between mental health, ecological factors, and problematic smartphone use: a network analysis in adolescents with major depressive disorder.

European archives of psychiatry and clinical neuroscience·2026
Same journal

The monocyte-to-HDL cholesterol ratio (MHR) modifies the association between dietary patterns and depression: a sex-specific analysis.

European archives of psychiatry and clinical neuroscience·2026
Same journal

Ictal electroencephalography and heart rate as treatment criteria in electroconvulsive therapy: a systematic review of the literature.

European archives of psychiatry and clinical neuroscience·2026
Same journal

Esketamine multi-omic biomarker evaluation in major depressive disorder (EMBER-MDD): concept, objectives and methodologies of a non-clinical investigator-initiated study.

European archives of psychiatry and clinical neuroscience·2026
Same journal

Differential burden of five major mental disorders in the United States across the COVID-19 pandemic.

European archives of psychiatry and clinical neuroscience·2026
See all related articles

Methadone maintenance treatments (MMTs) effectively reduce illicit opiate abuse, crime, HIV risks, and mortality. Treatment quality and duration significantly impact patient outcomes, improving social rehabilitation.

Area of Science:

  • Addiction Medicine
  • Pharmacology
  • Public Health

Background:

  • Opioid dependence poses significant public health challenges, including illicit drug abuse, criminality, and infectious disease transmission.
  • Methadone maintenance treatment (MMT) is a cornerstone therapy for opioid use disorder.

Purpose of the Study:

  • To review and synthesize available data on the efficacy of methadone maintenance treatments (MMTs).
  • To identify factors influencing treatment outcomes and patient retention.

Main Methods:

  • Systematic review of historical and recent scientific articles.
  • Analysis of patient and treatment variables influencing MMT effectiveness.

Main Results:

  • MMTs demonstrate significant efficacy in reducing illicit opiate use (50-80%), criminality, HIV risks, and mortality.

Related Experiment Videos

  • Long-term MMT (over 10 years) is utilized by a minority (5-20%) of patients.
  • Treatment factors like optimal dosage, quality of care, and retention are crucial for success, while patient factors like early onset of dependence and co-occurring drug abuse can be detrimental.

    • Conclusions:

    • MMTs are highly effective in improving outcomes for individuals with opioid dependence.
    • Optimizing treatment delivery, including dosage, psychosocial support, and duration, is key to maximizing MMT benefits and patient rehabilitation.